FDA Drug Application (202244) for RIZATRIPTAN BENZOATE by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number202244
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIZATRIPTAN BENZOATE
Active IngredientRIZATRIPTAN BENZOATE

Active IngredientCount
List of drugs with Active Ingredient RIZATRIPTAN BENZOATE3


Back to FDA Applications sponsored by APOTEX INC